New obesity drug combo shows promise in Mid-Stage trial
NCT ID NCT06577090
First seen Jan 17, 2026 · Last updated May 23, 2026 · Updated 18 times
Summary
This study tests a new drug called nimacimab, given as a weekly injection, to see if it helps people who are overweight or obese lose weight. Some participants will receive nimacimab alone, some with another weight-loss drug (semaglutide), and some a placebo. The trial involves 136 adults and focuses on safety and how much weight is lost over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
ACCEL Research Sites
Atlanta, Georgia, 30342, United States
-
Accellacare of Wilmington
Wilmington, North Carolina, 28401, United States
-
ActivMed Practices & Research
Portsmouth, New Hampshire, 03801, United States
-
Be Well Clinical Studies
Lincoln, Nebraska, 68516, United States
-
Be Well Clinical Studies
Round Rock, Texas, 78681, United States
-
Center for Advanced Research & Education
Gainesville, Georgia, 30501, United States
-
Charlottesville Medical Research
Charlottesville, Virginia, 22911, United States
-
Chase Medical Research, LLC
Waterbury, Connecticut, 06708, United States
-
Diablo Clinical Research, Inc.
Walnut Creek, California, 94598, United States
-
L-MARC Research Center
Louisville, Kentucky, 40213, United States
-
Lillestol Research, LLC
Fargo, North Dakota, 58104, United States
-
Palm Research Center
Las Vegas, Nevada, 89148, United States
-
Pinnacle Research Group
Anniston, Alabama, 36207, United States
-
Rainier Clinical Research Center
Renton, Washington, 98057, United States
-
Velocity Clinical Research, Dallas
Dallas, Texas, 75230, United States
-
Weill Cornell Medicine
New York, New York, 11375, United States
Conditions
Explore the condition pages connected to this study.